Status not kept up to date
Precise Transplantation of hAESCs Into the Ventricle for Parkinson's Disease.
NCT05435755 · Shanghai East Hospital · Updated 28 Oct 2022
- What is being tested
- hAESCs treatment; placebo (saline)
- For
- Parkinson's Disease
- Kind of study
- Tests a treatment or device on volunteers. Early phase 1.
- Who can join
- Ages 30 years to 70 years. About 12 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 2 Dec 2022, ends 30 Aug 2023. Registered 28 June 2022.
- Results
- None posted yet.
In the researchers' words
The purpose of this study is to evaluate the safety of multiple treatments of hAESCs treatments, while exploring the effectiveness of hAESCs treatments for PD.
Sites
- Jingwen WuShanghai, Shanghai Municipality, China